Look at the announcement, Xiao E is the first to report!

[Hot Spots].

Meiyingsen: The controlling shareholder reached an enforcement settlement with the creditor Zheshang Bank

Meiyingsen (002303) announced on the evening of October 13 that the company received a notice from Wang Haipeng, the controlling shareholder and actual controller, that it had reached a settlement with Zheshang Bank on the financial business contract dispute, and received the "Enforcement Settlement Agreement" stamped and effective by Zheshang Bank on October 12. According to the terms of the settlement, Wang Haipeng agreed to use 735 million yuan as the principal of the debt he owed, and repay the loan to Zheshang Bank as agreed. Wang Haipeng guaranteed that his divorce case would not affect the normal performance of the enforcement settlement agreement, and would not cause any adverse impact on Zheshang Bank's realization of creditor's rights, security rights and other rights. The settlement will not have a direct impact on the company's normal production and operation, business development, corporate governance, etc.

JinkoSolar: From January to September, the cumulative amount of new borrowings was 9.932 billion yuan

JinkoSolar (688223) announced on the evening of October 13 that the company's cumulative new borrowings from January to September 2024 were 9.932 billion yuan, accounting for 28.91% of the net assets attributable to shareholders of listed companies at the end of 2023. The above-mentioned new borrowings are necessary to ensure the production and operation of the Company and its holding subsidiaries, and are conducive to promoting the sustainable and stable development of the Company's existing business. Up to now, the company's operating conditions are stable, all business operations are normal, all debts are repaid on time, and the above-mentioned new borrowings will not have a material adverse impact on the company's solvency.

[Performance].

Espressif Technology: Net profit in the first three quarters is expected to increase by about 188% year-on-year

Espressif Technology (688018) announced on the evening of October 13 that it expects to achieve a net profit of about 251 million yuan in the first three quarters of 2024, an increase of about 188% year-on-year. In 2023 and 2024, the company will add a number of potential customers, and the projects of these downstream customers will gradually enter the stage of large-scale production, contributing to the main growth. Espressif's products are used in the pan-IoT field, focusing on long-term digital upgrades, rather than relying on short-term explosive growth in a specific industry or customer.

Fuchun Environmental Protection: Net profit in the first three quarters increased by 80%-110% year-on-year

Fuchun Environmental Protection (002479) announced on the evening of October 13 that it is expected to achieve a net profit of 233 million yuan to 272 million yuan in the first three quarters of 2024, a year-on-year increase of 80%-110%. During the reporting period, the company's parent company received 100 million yuan in compensation for demolition, which was included in the current profit and loss in the third quarter, which is expected to increase the total non-recurring profit and loss of the current period by about 97.37 million yuan; In addition, with the decline in the cost of raw materials in the company's cogeneration business segment and the increase in the production scale of the solid waste (hazardous waste) resource business segment, the company's overall operating situation is improving.

Kaierda: Net profit in the first three quarters increased by 70.92%-89.23% year-on-year

Kaierda (688255) announced on the evening of October 13 that the company is expected to achieve a net profit of 28 million yuan to 31 million yuan in the first three quarters of 2024, a year-on-year increase of 70.92% to 89.23%. The company focuses on the welding robot market, and during the reporting period, the differentiated competitiveness, market acceptance and recognition of the company's robot-related products continued to improve, and the company's performance increased significantly.

Shanghai Electric Power: Net profit in the first three quarters increased by 53.3%-82.44% year-on-year

Shanghai Electric Power (600021) announced on the evening of October 13 that it is expected to achieve a net profit of 2.252 billion yuan to 2.68 billion yuan from January to September 2024, an increase of 53.3%-82.44% year-on-year. The performance growth is mainly due to the continuous improvement of the marginal income of coal power and the improvement of the efficiency of coal power enterprises holding and participating in shares; The company has accelerated its green transformation and development, and the installed capacity and efficiency of clean energy power generation at home and abroad have increased.

Lante Optics: Net profit in the first three quarters increased by 72.09%-82.99% year-on-year

Lante Optics (688127) announced on the evening of October 13 that it is expected to achieve a net profit of 158 million yuan to 168 million yuan in the first three quarters of 2024, an increase of 72.09% to 82.99% year-on-year. During the reporting period, the company continued to adhere to the precision optical components market, and by grasping the development opportunities in the fields of consumer electronics and automotive intelligent driving, the company's sales revenue in major product segments such as optical prisms, glass aspheric lenses, and glass wafers have increased.

Smartway: It is expected that the net profit in the first three quarters will be 252 million yuan - 292 million yuan year-on-year

SmartSens (688213) announced on the evening of October 13 that it is expected to achieve a net profit of 252 million yuan to 292 million yuan in the first three quarters of 2024, compared with a loss of 65.47 million yuan in the same period last year. During the reporting period, the company's newly launched iterative products in the field of smart security have better performance and competitiveness, product sales have increased significantly, and sales revenue has increased significantly; In the field of smart phones, the company's shipments of several high-end 50 million pixel products used in the main camera, wide-angle, telephoto and front camera lenses of flagship mobile phones have increased significantly, driving the company's revenue in the field of smart phones to grow significantly, and successfully opening up a second growth curve.

Zongyi shares: net profit of 72.1468 million yuan in the first three quarters year-on-year

Zongyi Co., Ltd. (600770) released its third quarterly report on the evening of October 13, and the company's operating income in the first three quarters was 252 million yuan, a year-on-year decrease of 7.79%; The net profit was 72.1468 million yuan, a year-on-year turnaround. The change in net profit in the reporting period was mainly due to the change in the fair value of the financial assets invested and held by the subsidiary.

Shenke shares: It is expected that the net profit in the first three quarters will be 7 million yuan - 8.5 million yuan year-on-year

Shenke Co., Ltd. (002633) announced on the evening of October 13 that it is expected that the net profit in the first three quarters of 2024 will be 7 million yuan to 8.5 million yuan, a year-on-year turnaround. In the same period last year, the company lost 7.5576 million yuan. From January to September 2024, the company's operating income increased over the same period of the previous year, the gross profit of products rebounded steadily, and the net profit increased over the same period of the previous year.

VeriSilicon: net profit in the third quarter was 111 million yuan, and the loss narrowed year-on-year

VeriSilicon (688521) announced on the evening of October 13 that it expects a net profit of 111 million yuan in the third quarter of 2024, a year-on-year decrease of 45.3825 million yuan. The company maintained the trend of operating improvement in the third quarter, and the operating income is expected to be 718 million yuan, an increase of 16.96% month-on-month and 23.6% year-on-year. The company expects that the new orders signed in the third quarter of 2024 will be 648 million yuan, and the orders in hand will be 2.138 billion yuan by the end of the third quarter of 2024, and the orders in hand have remained high for four consecutive quarters, of which the proportion of revenue is expected to be 78.26% within one year. The company's order situation is good, laying a solid foundation for future performance transformation.

Zhenghai Magnetics: net profit in the first three quarters was 189 million yuan, down 48.53% year-on-year

Zhenghai Magnetics (300224) released its third quarterly report on the evening of October 13, achieving operating income of 3.81 billion yuan in the first three quarters, a year-on-year decrease of 17.67%; net profit was 189 million yuan, down 48.53% year-on-year. During the reporting period, the company's new energy vehicle motor drive business was sluggish, with operating income and profit declining sharply year-on-year, and the business space was shrinking and showing a continuous compression trend.

Xinlian Integration: The net profit in the first three quarters was about 684 million yuan, a year-on-year decrease

Xinlian Integration (688469) announced on the evening of October 13 that it is expected to lose about 684 million yuan in net profit in the first three quarters of 2024, a decrease of about 677 million yuan compared with the same period last year. During the reporting period, the company's new products such as SiC and 12-inch silicon-based wafers were rapidly introduced and mass-produced by leading customers, and the company's operating income rose rapidly, showing high growth year-on-year and quarter-on-quarter in a single quarter. In the third quarter of 2024, the company's operating income was about 1.668 billion yuan, a record high. In the third quarter of 2024, the company's gross profit margin has turned positive in a single quarter, about 6%.

[Repurchase].

Huada New Materials: The chairman proposed 100 million yuan to 200 million yuan to repurchase the company's shares

Huada New Materials (605158) announced on the evening of October 13 that Shao Mingxiang, chairman of the company, proposed to repurchase the company's shares with 100 million yuan to 200 million yuan, and the repurchased shares are intended to be used for the implementation of equity incentives or cancellation in the future.

[Increase or decrease in holdings].

Zhende Medical: One of the controlling shareholders terminated the shareholding reduction plan ahead of schedule

Zhende Medical (603301) announced on the evening of October 13 that previously, the company's controlling shareholder Xuchang Zhende Landscaping Engineering Co., Ltd. (hereinafter referred to as "Xuchang Garden") intends to reduce its holdings of no more than 3% of the company's shares, and the company received a notification letter issued by Xuchang Garden on October 11, and Xuchang Garden decided to terminate the share reduction plan. Up to now, Xuchang Garden has not reduced its shareholding in the company.

Haoyue Nursing: The employee stock ownership platform hopes that Zhongchuang will terminate the shareholding reduction plan ahead of schedule

Haoyue Nursing (605009) announced on the evening of October 13 that previously, Hangzhou Hope Zhongchuang Industrial Investment Partnership (Limited Partnership) (hereinafter referred to as "Hope Zhongchuang"), the concerted action of the company's controlling shareholder, planned to reduce its holdings of no more than 1.5 million shares of the company. As of October 11, 2024, Hope Zhongchuang has not reduced its shareholding in the company and will terminate the shareholding reduction plan in advance. It is hoped that Zhongchuang is a shareholding platform for some employees, actual controllers and their relatives of the company.

Kemei Diagnostics: Shanghai Peixi and others plan to reduce their holdings of no more than 3% of the company's shares

Kemei Diagnostics (688468) announced on the evening of October 13 that the shareholder Shanghai Peixi Investment Management Partnership (Limited Partnership) (hereinafter referred to as "Shanghai Peixi") and its concerted actor HJ CAPITAL hold a total of 7.23% of the company's shares, and plan to reduce the company's shares by a total of no more than 12,033,200 shares, that is, no more than 3% of the company's total shares.

[Medical Progress].

Dizhe Pharmaceutical: The first-line treatment of Suwozhe was granted Breakthrough Therapy Designation by the CDE

Dizhe Pharmaceutical (688192) announced on the evening of October 13 that recently, the Center for Drug Evaluation (CDE) of the State Food and Drug Administration (hereinafter referred to as "CDE") granted breakthrough therapy designation to the company's first self-developed new lung cancer targeted drug, Suvotinib (generic name: Suvotinib Tablets), for locally advanced or metastatic non-small cell lung cancer (NSCLC) that has not received systemic therapy and carries epidermal growth factor receptor (EGFR) exon 20 insertion mutation (Exon20ins). The first-line treatment of Suvozer was granted "Breakthrough Therapy Designation" by the CDE, which is a high affirmation of the company's R&D strength and breakthrough innovation R&D achievements by the regulatory registration authority, which will help the company accelerate the development and marketing of Suvozer's first-line treatment EGFR Exon20ins NSCLC.

Baili Tianheng: BL-M11D1 clinical trial application was approved by the United States FDA

Baili Tianheng (688506) announced on the evening of October 13 that its wholly-owned subsidiary, SystImmune, Inc., recently received a notice from the United States Food and Drug Administration ("FDA") that the phase I clinical trial application of BL-M11D1 (CD33-ADC) for the treatment of patients with relapsed or refractory acute myeloid leukemia has been approved by the FDA. The IND approval of the FDA for the clinical study of BL-M11D1 will further promote the process of the company's business and product internationalization.

Hengrui Pharmaceutical: The marketing authorization application for SHR2554 tablets was accepted

Hengrui Pharmaceutical (600276) announced on the evening of October 13 that the company received the "Notice of Acceptance" issued by the State Food and Drug Administration, and the company's SHR2554 drug marketing authorization application was accepted by the State Food and Drug Administration, and was included in the public list of varieties to be prioritized for review. The proposed indication of this drug is for the treatment of relapsed or refractory peripheral T-cell lymphoma who have received at least one prior line of systemic therapy.

Borui Pharmaceutical: Phase II clinical trial of BGM0504 injection for weight loss indication achieved the expected goal

Borui Pharmaceutical (688166) announced on the evening of October 13 that the phase II clinical trial of BGM0504 injection independently developed by its wholly-owned subsidiary, Borui Xinchuang, for the treatment of non-diabetic overweight or obesity has reached the expected goal. This provides data support and reference for the follow-up clinical study of BGM0504 injection, but the final weight loss efficacy needs to be further confirmed by the follow-up phase III confirmatory clinical study in Chinese non-diabetic overweight or obese subjects with a large sample size.

[M&A and reorganization].

Guangzhi Technology: It is planned to purchase 100% of the shares of Pioneer Conductive Technology, a PVD sputtering target company

Guangzhi Technology (300489) disclosed a major asset restructuring plan on the evening of October 13, the company intends to purchase 100% of the shares of Pioneer Electronic Technology Co., Ltd. (hereinafter referred to as "Leadtek") held by all 55 shareholders of Pioneer Electronic Technology Co., Ltd. (hereinafter referred to as "Leadtek") by issuing shares and paying cash, and at the same time intends to issue shares to no more than 35 specific investors to raise matching funds. The transaction price for LEAD's 100% stake has not yet been determined. LEAD is committed to the R&D, production and sales of advanced PVD sputtering targets and evaporation materials, as well as the recycling, purification, preparation and sales of high-purity dispersed metals and compounds, which are mainly used in downstream markets including display panels, advanced photovoltaics, semiconductors and new solid-state fuel cells. Through this reorganization, the main business of LEAD will effectively enrich the company's business chain and expand the company's main business scope. Before this transaction, the controlling shareholder of the company was Yuebang Investment, and the actual controller was Zhu Shihui. After the completion of the transaction, the controlling shareholder of the company is expected to be changed to Pilot Rare Materials, and the actual controller is still Zhu Shihui. The company's shares will resume trading from the opening of the market on October 14.

Jingwei Huikai: It plans to acquire the share of Nord Trust's partnership to further lay out the semiconductor field

Jingwei Huikai (300120) announced on the evening of October 13 that the company and its subsidiary Jiangsu Xinhuikai plan to acquire 97.1729% of the partnership share of Nuoxin Enterprise Management Consulting Partnership (Limited Partnership) (hereinafter referred to as "Nordtrust") in Tianjin Economic and Technological Development Zone, with a total transaction price of 120.3 million yuan. Among them, the company plans to acquire 96.3651% of the share of Nord Trust, with a transaction price of 119.3 million yuan; Jiangsu Xinhui Kai plans to acquire a 0.8078% share of Nord Promise at a transaction price of 1 million yuan. THE COUNTERPARTIES TO THE TRANSACTION ARE 38 PARTNERS OF NORTSIL, INCLUDING CHEN JIANBO, CHAIRMAN AND GENERAL MANAGER OF THE COMPANY, HIS BROTHER CHEN JIANXIANG, LIU ZHENGBING, DIRECTOR, CHAI CUIHONG, SPOUSE OF HOO YONG KEONG, DIRECTOR AND DEPUTY GENERAL MANAGER, AND LI CHUNXIU, MOTHER OF INDEPENDENT DIRECTOR HE YONGQIANG. Since its establishment, Nord Promise has not engaged in other businesses, and has only invested in North (Tianjin) Microsystem Co., Ltd. (hereinafter referred to as "North Micro"), which currently holds a 7.9245% stake in North Micro. Northmicro is mainly engaged in the design, R&D, production and sales of RF front-end bulk acoustic wave filter chips (BAW) and modules. Before the transaction, the company directly held 9.188% of the equity of Northway, and after the completion of the transaction, the company controlled 17.1125% of the equity of Northway. This transaction is conducive to the company's further realization of its strategic layout in the semiconductor field.

[Investment].

Tellhow Technology: It plans to increase its capital by 800 million yuan to its wholly-owned subsidiary by way of debt-to-equity swap

Tellhow Technology (600590) announced on the evening of October 13 that in order to grasp the strategic development opportunity period of the national emergency industry, strengthen the business competitive advantage of its wholly-owned subsidiary, Tellhow Power Technology Co., Ltd. (hereinafter referred to as "Tellhow Power"), and optimize its asset-liability structure, the company intends to increase its capital by 800 million yuan by way of debt-to-equity swap, and after the completion of the capital increase, Tellhow Power is still a wholly-owned subsidiary of the company.

[Refinancing].

Xilinmen: It is planned to raise no more than 850 million yuan from the subsidiary of the controlling shareholder

Xilinmen (603008) disclosed on the evening of October 13 the plan to issue A-shares to specific objects in 2024, and intends to raise no more than 850 million yuan from Xinhong Investment for the Xilinmen Smart Home Industrial Park project (Phase II) and supplementary liquidity, with an issue price of 12.81 yuan per share. Xinhong Investment is a wholly-owned subsidiary of the company's controlling shareholder.

[Other].

Gekewei: 50 million pixel image sensor products were mass-produced and shipped

Geke Micro (688728) announced on the evening of October 13 that recently, the company's 50 million pixel image sensor products have been mass-produced and shipped. The product is mass-produced and shipped, and enters the main camera market of high-end brand mobile phones at home and abroad, which will help consolidate and enhance the company's core competitiveness and will have a positive impact on the company's future development.

ST Guangwu: The company and related personnel were fined a total of 19 million yuan for financial fraud

ST Guangwu (600603) announced on the evening of October 13 that on October 12, the company received the "Administrative Penalty Decision" issued by the China Securities Regulatory Commission. Due to false records in the 2022 annual report and 2023 semi-annual report, the company and related responsible persons were fined a total of 19 million yuan. Among them, ST Guangwu was given a warning and fined 5 million yuan; Yang Tiejun, the chairman of the board at the time, organized and arranged the implementation of false delivery materials, and was fined 2.5 million yuan and banned from the market for 5 years. ST Guangwu said that up to now, the company's production and operation activities have been carried out in a normal and orderly manner. For the relevant matters involved in the "Administrative Penalty Decision", the company has carried out profound self-examination and self-correction and has completed rectification.

Oujing Technology: Downward revision of the "Oujing Convertible Bond" conversion price

Oujing Technology (001269) announced on the evening of October 13 that the conversion price of "Oujing Convertible Bonds (127098)" was revised downward, with the conversion price before the correction being 44.71 yuan/share, and the revised conversion price being 42 yuan/share, and the effective date of the revised conversion price is October 14, 2024.